Empire Genomics is a company that designs, manufactures, and distributes clinical and custom labeled molecular probes for biomarker research and diagnostics. Its product portfolio includes fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH) probes that are designed and optimized for specific diseases, genes, and regions across the entire human or mouse genomes. The company serves clinical laboratories, biotechnology organizations, and academic institutions.